Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-25 @ 4:44 PM
NCT ID: NCT02129803
Description: None
Frequency Threshold: 0
Time Frame: Length of hospital stay - up to 3 months
Study: NCT02129803
Study Brief: Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Experimental Therapy High-Flow, 20 LPM (via Optiflow cannula) Heated (34C) Humidified Air High-Flow, 20 LPM (via Optiflow cannula): Nasal high flow humidification (20LPM) therapy will be administered using Optiflow with Airvo 2. 0 None 0 6 2 6 View
Control Therapy (Low Flow) Low FLow, 5 LPM (via Optiflow cannula) Room Temperature (23-26C) Ambient Air Low FLow, 5 LPM (via Optiflow cannula): standard humidified wall medical air. 0 None 0 9 1 9 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nasal discomfort NON_SYSTEMATIC_ASSESSMENT Product Issues None View